12:00 AM
May 27, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Schizophrenia Calcium channel voltage-dependent N type-a 1B subunit (CACNA1B; Cav2.2); double C2-like...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >